Experimental Research Center, First People's Hospital, Shanghai Jiao Tong University, Shanghai, China.
Nat Med. 2011 Jul 3;17(7):860-6. doi: 10.1038/nm.2385.
In cancer treatment, apoptosis is a well-recognized cell death mechanism through which cytotoxic agents kill tumor cells. Here we report that dying tumor cells use the apoptotic process to generate potent growth-stimulating signals to stimulate the repopulation of tumors undergoing radiotherapy. Furthermore, activated caspase 3, a key executioner in apoptosis, is involved in the growth stimulation. One downstream effector that caspase 3 regulates is prostaglandin E(2) (PGE(2)), which can potently stimulate growth of surviving tumor cells. Deficiency of caspase 3 either in tumor cells or in tumor stroma caused substantial tumor sensitivity to radiotherapy in xenograft or mouse tumors. In human subjects with cancer, higher amounts of activated caspase 3 in tumor tissues are correlated with markedly increased rate of recurrence and death. We propose the existence of a cell death-induced tumor repopulation pathway in which caspase 3 has a major role.
在癌症治疗中,细胞凋亡是一种公认的细胞死亡机制,细胞毒性药物通过该机制杀死肿瘤细胞。在这里,我们报告说,垂死的肿瘤细胞利用凋亡过程产生有效的生长刺激信号,刺激正在接受放射治疗的肿瘤的再增殖。此外,凋亡的关键执行者激活的半胱天冬酶 3 参与了生长刺激。半胱天冬酶 3 调节的下游效应物之一是前列腺素 E2(PGE2),它可以强烈刺激存活的肿瘤细胞生长。在异种移植或小鼠肿瘤中,肿瘤细胞或肿瘤基质中 caspase 3 的缺乏导致对放射治疗的敏感性大大增加。在患有癌症的人类患者中,肿瘤组织中激活的 caspase 3 数量较多与复发和死亡的明显增加有关。我们提出了一种细胞死亡诱导的肿瘤再增殖途径的存在,其中半胱天冬酶 3 具有主要作用。